Cranbrook Wealth Management’s Organon & Co OGN Stock Holding History

Cranbrook Wealth Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01K	Hold	169	–	–	﹤0.01%	371
2025 Q4	$1.21K	Hold	169	–	–	﹤0.01%	386
2025 Q3	$1.8K	Hold	169	–	–	﹤0.01%	371
2025 Q2	$1.64K	Sell	169 -10	-6%	-$103	﹤0.01%	375
2025 Q1	$2.67K	Sell	179 -1	-0.6%	-$15	﹤0.01%	357
2024 Q4	$2.69K	Hold	180	–	–	﹤0.01%	337
2024 Q3	$3.44K	Buy	180 +1	+0.6%	+$21	﹤0.01%	314
2024 Q2	$3.71K	Hold	179	–	–	﹤0.01%	279
2024 Q1	$3.37K	Hold	179	–	–	﹤0.01%	263
2023 Q4	$2.58K	Buy	179 +10	+6%	+$136	﹤0.01%	277
2023 Q3	$2.93K	Sell	169 -16	-9%	-$334	﹤0.01%	265
2023 Q2	$3.85K	Hold	185	–	–	﹤0.01%	260
2023 Q1	$4.35K	Hold	185	–	–	﹤0.01%	261
2022 Q4	$5.17K	Hold	185	–	–	﹤0.01%	248
2022 Q3	$4K	Hold	185	–	–	﹤0.01%	276
2022 Q2	$6K	Hold	185	–	–	﹤0.01%	264
2022 Q1	$7K	Hold	185	–	–	﹤0.01%	293
2021 Q4	$6K	Hold	185	–	–	﹤0.01%	315
2021 Q3	$6K	Hold	185	–	–	﹤0.01%	327
2021 Q2	$6K	Buy	+185	New	+$6.09K	﹤0.01%	304

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Cranbrook Wealth Management's OGN Position: Q1 2026 in Review

Cranbrook Wealth Management held its Organon & Co (OGN) position steady in Q1 2026 at 169 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #371.

Cranbrook Wealth Management first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $7K in Q1 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

Cranbrook Wealth Management held 169 shares of Organon & Co worth $1.01K as of Q1 2026.
Cranbrook Wealth Management left its Organon & Co share count unchanged in Q1 2026.
Organon & Co made up ﹤0.01% of Cranbrook Wealth Management's portfolio in Q1 2026, its #371 holding.
Cranbrook Wealth Management first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
Cranbrook Wealth Management's Organon & Co position peaked at $7K in Q1 2022.
603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Cranbrook Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.